Guidelines on nicotine dose selection for in vivo research
The DOI matches its Crossref record; 451 of the 451 references it cites were found in a registry or an index.
Abstract
Rationale This review provides insight for the judicious selection of nicotine dose ranges and routes of administration for in vivo studies. The literature is replete with reports in which a dosaging regimen chosen for a specific nicotine-mediated response was suboptimal for the species used. In many cases, such discrepancies could be attributed to the complex variables comprising species-specific in vivo responses to acute or chronic nicotine exposure. Objectives This review capitalizes on the authors' collective decades of in vivo nicotine experimentation to clarify the issues and to identify the variables to be considered in choosing a dosaging regimen. Nicotine dose ranges tolerated by humans and their animal models provide guidelines for experiments intended to extrapolate to human tobacco exposure through cigarette smoking or nicotine replacement therapies. Just as important are the nicotine dosaging regimens used to provide a mechanistic framework for acquisition of drug-taking behavior, dependence, tolerance, or withdrawal in animal models. Results Seven species are addressed: humans, nonhuman primates, rats, mice, Drosophila, Caenorhabditis elegans, and zebrafish. After an overview on nicotine metabolism, each section focuses on an individual species, addressing issues related to genetic background, age, acute vs chronic exposure, route of administration, and behavioral responses. Conclusions The selected examples of successful dosaging ranges are provided, while emp…
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“When extracting and comparing doses across studies it is critical to evaluate whether doses were reported in free base weight or salt weight as there are large differences between the two forms (Matta et al., 2007).”
From Age-dependent Effects of Tobacco Smoke and Nicotine on Cognition and the Brain: A Systematic Review of the Human and Animal Literature Comparing Adolescents and Adults. (2023) · cites this paper as Matta et al., 2007
In the citing paper
“Mice metabolise nicotine at a faster rate than rats (Matta et al., 2007).”
From Age-dependent Effects of Tobacco Smoke and Nicotine on Cognition and the Brain: A Systematic Review of the Human and Animal Literature Comparing Adolescents and Adults. (2023) · cites this paper as Matta et al., 2007
In the citing paper
“The routes of administration and doses of nicotine in studies can vary widely (Table 1, [152].”
From Adolescent nicotine exposure and persistent neurocircuitry changes: unveiling lifelong psychiatric risks (2025) · cites this paper as [152]
In the citing paper
“nicotine is rapidly metabolized, resulting in a very short half-life in the mouse of 6–7 min”
From Parallel Anxiolytic-Like Effects and Upregulation of Neuronal Nicotinic Acetylcholine Receptors Following Chronic Nicotine and Varenicline (2011) · cites this paper as Matta et al., 2007
In the citing paper
“The experiments use a nicotine concentration (0.1 µM) somewhat less than that in the blood within a few min after a human smokes a cigarette, and perhaps more appropriate to the average values during a day of smoking (Matta et al., 2007).”
From Nicotine up-regulates α4β2 nicotinic receptors and ER exit sites via stoichiometry-dependent chaperoning (2011) · cites this paper as Matta et al., 2007
4 more claims about this paper
Create a free account to see every claim other papers make about this one.
Citations
Cites
Items 201–400 of 451
Early expression of acetylcholinesterase activity in functionally distinct neurons of the zebrafish
Hanneman, E., & Westerfield, M. (1989) · Journal of Comparative Neurology · doi:10.1002/cne.902840303 · Cited by 125 · cited 1×
“In addition, acetylcholinesterase-positive cells in developing embryos have been shown to be necessary for normal neuromuscular and neuronal development (Behra et al. 2002; Hanneman and Westerfield 1989).”
BackgroundNeural responses to bitter compounds in rats
Dahl, M., Erickson, R. P., & Simon, S. A. (1997) · Brain Research · doi:10.1016/s0006-8993(97)00131-5 · Cited by 125
Garcia, L. R., Mehta, P., & Sternberg, P. W. (2001) · Cell · doi:10.1016/s0092-8674(01)00600-6 · Cited by 125 · cited 1×
“In liquid culture, 258 μM nicotine in water causes spicule protraction in 90% of wt males (Garcia et al. 2001).”
BackgroundStrain comparison of nicotine-induced seizure sensitivity and nicotinic receptors
Miner, L. L., & Collins, A. C. (1989) · Pharmacology Biochemistry and Behavior · doi:10.1016/0091-3057(89)90532-7 · Cited by 125 · cited 1×
“2002), while for mice it is 2–6 mg kg depending on strain (Miner and Collins 1989).”
BackgroundSelf-citationDose‐Response Relationship for Nicotine‐Induced Up‐Regulation of Rat Brain Nicotinic Receptors
Rowell, P. P., & Li, M. (1997) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1997.68051982.x · Cited by 124
Modulation of Drosophila heartbeat by neurotransmitters
Johnson, E. C., Ringo, J. M., & Dowse, H. B. (1997) · Journal of Comparative Physiology B · doi:10.1007/s003600050051 · Cited by 123
Nicotine enhances contextual fear conditioning in C57BL/6J mice at 1 and 7 days post-training
Gould, T. J., & Stephen Higgins, J. (2003) · Neurobiology of Learning and Memory · doi:10.1016/s1074-7427(03)00057-1 · Cited by 123
Hildebrand, B. E., Nomikos, G. G., Bondjers, C., Nisell, M., & Svensson, T. H. (1997) · Psychopharmacology · doi:10.1007/s002130050200 · Cited by 122
Paralytic Zebrafish Lacking Acetylcholine Receptors Fail to Localize Rapsyn Clusters to the Synapse
Ono, F., Higashijima, S.-I., Shcherbatko, A., Fetcho, J. R., & Brehm, P. (2001) · The Journal of Neuroscience · doi:10.1523/jneurosci.21-15-05439.2001 · Cited by 121
Pratt, J. A., Stolerman, I. P., Garcha, H. S., Giardini, V., & Feyerabend, C. (1983) · Psychopharmacology · doi:10.1007/bf00439274 · Cited by 121 · cited 1×
“At a training dose of 400 μg kg, nicotine produces a strong stimulus that is discriminated with at least 80% accuracy by the majority of rats after 30–40 training sessions (Chance et al. 1977; Pratt et al. 1983), whereas a 100-μg-kg training dose requires nearly 60 sessions and is acquired with high accuracy by only 6…”
BackgroundSelf-citationWhite, H. K., & Levin, E. D. (2004) · Psychopharmacology · doi:10.1007/s00213-003-1614-8 · Cited by 121 · cited 2×
“Chronic nicotine skin patches have been used to improve attentiveness in people with mild to moderate Alzheimer’s disease (White and Levin 1999), those with age-associated memory impairment (White and Levin 2004) as well as adults with ADHD (Levin et al.”
BackgroundMethodSelf-citationPharmacodynamic effects of new de-nicotinized cigarettes
Pickworth, W., Fant, R., Nelson, R., Rohrer, M., & Henningfield, J. (1999) · Nicotine & Tobacco Research · doi:10.1080/14622299050011491 · Cited by 119 · cited 1×
“Several denicotinized or of reduced nicotine content tobacco cigarettes have been tested (Pickworth et al. 1999) and cigarettes containing tobacco with varying nicotine content are now commercially available (Quest brand).”
BackgroundThe occurrence of tolerance to a central depressant effect of nicotine
MORRISON, C. F., & STEPHENSON, J. A. (1972) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.1972.tb06857.x · Cited by 119
Nicotine and Cotinine Concentrations in the Nursing Mother and Her Infant
DAHLSTRÖM, A., LUNDELL, B., CURVALL, M., & THAPPER, L. (1990) · Acta Paediatrica · doi:10.1111/j.1651-2227.1990.tb11430.x · Cited by 118 · cited 1×
“…between nicotine concentrations in breast milk and serum, although breast milk nicotine concentration is 2.5–2.9 times greater because it is relatively more acidic (pH 6.8–7.0) than serum (pH 7.4) and nicotine partitions into the more acidic medium (Dahlstrom et al. 1990; Luck et al. 1985).”
BackgroundInfluentialNisell, M., Marcus, M. M., Nomikos, G. G., & Svensson, T. H. (1997) · Journal of Neural Transmission · doi:10.1007/bf01271290 · Cited by 118
(?)-nicotine produces conditioned place preference in Lewis, but not Fischer 344 rats
Horan, B., Smith, M., Gardner, E. L., Lepore, M., & Ashby, C. R. (1997) · Synapse · doi:10.1002/(sici)1098-2396(199705)26:1<93::aid-syn10>3.0.co;2-w · Cited by 118
Sensory blockade of smoking satisfaction
Rose, J. E., Tashkin, D. P., Ertle, A., Zinser, M. C., & Lafer, R. (1985) · Pharmacology Biochemistry and Behavior · doi:10.1016/0091-3057(85)90572-6 · Cited by 117 · cited 1×
“Several methods of controlling puff volume and inhalation volume have been devised, which can effectively regulate the dose of nicotine inhaled (Gilbert et al. 1989; Levin et al. 1989; Pomerleau et al. 1989; Rose et al. 1985; Tashkin et al. 1991).”
MethodSelf-citationThe Metabolism of Tobacco Alkaloids
Gorrod, J. W., & Jenner, P. G. (1975) · Essays in toxicology · doi:10.1016/b978-0-12-107606-1.50008-2 · Cited by 116 · cited 1×
“The metabolism in primates is comparable to that in humans (Seaton et al. 1991), but other animals metabolize nicotine more rapidly (Gorrod and Jenner 1975; Scheline 1978; Seaton and Vesell 1993).”
BackgroundLaviolette, S. R., & van der Kooy, D. (2003) · Psychopharmacology · doi:10.1007/s00213-002-1317-6 · Cited by 113
DeNoble, V. J., & Mele, P. C. (2005) · Psychopharmacology · doi:10.1007/s00213-005-0054-z · Cited by 113 · cited 1×
“relatively unlimited daily nicotine intake in regular smokers (Brower et al. 2002; DeNoble and Mele 2006; Fu et al. 2001; Kenny and Markou 2006; LeSage et al. 2003; Paterson and Markou 2004; Valentine et al. 1997).”
BackgroundVulnerability of125I-α-Conotoxin MII Binding Sites to Nigrostriatal Damage in Monkey
Quik, M., Polonskaya, Y., Kulak, J. M., & McIntosh, J. M. (2001) · The Journal of Neuroscience · doi:10.1523/jneurosci.21-15-05494.2001 · Cited by 112 · cited 1×
“The transcripts for the α2 through α7 and β2 through β4 nAChR subunits have been identified and expressed in nonhuman primate neuronal tissues, with numerous receptor subtypes present in multiple brain regions (Cimino et al. 1992; Han et al. 2000, 2003; Quik 2004; Quik et al. 2000, 2001, 2005).”
BackgroundSelf-citationBeneficial effects of nicotine
JARVIK, M. E. (1991) · British Journal of Addiction · doi:10.1111/j.1360-0443.1991.tb01810.x · Cited by 111 · cited 2×
“…and in macaques (Macaca mulatta, Macaca fascicularis, and Macaca nemestrina) with doses generally ranging from 0.001 to 0.056 mg kg −1 (0.3–18 μg kg −1 ) (Buccafusco and Jackson 1991; Buccafusco et al. 1995, 1999; Elrod et al. 1988; Katner et al. 2004; Prendergast et al. 1997; Terry et al. 1993;…”
BackgroundInfluentialLevin, E. D., Christopher, N. C., Briggs, S. J., & Rose, J. E. (1993) · Cognitive Brain Research · doi:10.1016/0926-6410(93)90021-v · Cited by 110
Self-citationAversion instead of preference learning indicated by nicotine place conditioning in rats
Jorenby, D. E., Steinpreis, R. E., Sherman, J. E., & Baker, T. B. (1990) · Psychopharmacology · doi:10.1007/bf02244233 · Cited by 110 · cited 1×
“4 mg kg (Le Foll and Goldberg 2005a), although under some conditions conditioned place aversion can be produced by moderate (0.8 mg kg; Jorenby et al. 1990) and high nicotine doses (1.”
BackgroundInfluentialHildebrand, B. E., Panagis, G., Svensson, T. H., & Nomikos, G. G. (1999) · Neuropsychopharmacology · doi:10.1016/s0893-133x(99)00055-x · Cited by 110
Suppression of nicotine intake during ad libitum cigarette smoking by high-dose transdermal nicotine
Benowitz, N. L., Zevin, S., & Jacob, P. (1998) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)37887-5 · Cited by 108 · cited 2×
“However, studies of the effects of using NRT concurrently with cigarette smoking, as well as studies of high-dose NRT, using multiple skin patches or combinations of two or more forms of NRT, have found no evidence of serious toxic effects (Benowitz 2004; Benowitz et al. 1998; Schuurmans et al. 2004; Working Group for…”
BackgroundSelf-citationFoll, B. L., & Goldberg, S. R. (2005) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2005.04.005 · Cited by 108
Benowitz, N. L., Zevin, S., & Jacob, P. (1997) · British Journal of Clinical Pharmacology · doi:10.1111/j.1365-2125.1997.00566.x · Cited by 107 · cited 3×
“…dose with Nicotrol NS (0.5 mg per spray × two sprays), the nicotine spray product approved by the Food and Drugs Administration, the arterial nicotine peaks at 10 ng ml −1 (0.06 μM) within 5 min, while venous levels peak at about 4 ng ml −1 (0.02 μM) after 25–20 min (Gourlay and Benowitz 1997).”
BackgroundInfluentialSelf-citationConditioned nicotine withdrawal profoundly decreases the activity of brain reward systems
Kenny, P. J., & Markou, A. (2005) · The Journal of Neuroscience · doi:10.1523/jneurosci.4785-04.2005 · Cited by 107 · cited 1×
“The discrepancy in nicotine-induced alterations in brain reward threshold between non-contingent high-dose nicotine and self-administered nicotine may be attributable to dose (Kenny and Markou 2005; Skjei and Markou 2003).”
BackgroundSelf-citationPaterson, N. E., & Markou, A. (2004) · Psychopharmacology · doi:10.1007/s00213-003-1692-7 · Cited by 106 · cited 4×
“Both paradigms result in physical dependence, as measured by mecamylamine-precipitated somatic withdrawal signs and alterations in brain reward thresholds (see “Nicotine dependence and withdrawal”), although the duration of dependence may be greater after extended access self-administration (6 h; Kenny and Markou 2006…”
BackgroundInfluentialSelf-citationGenotype influences the development of tolerance to nicotine in the mouse.
Marks, M. J., Campbell, S. M., Romm, E., & Collins, A. C. (1991) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)20539-0 · Cited by 105 · cited 1×
“This method has been used to evaluate the role of genotype in tolerance development (Marks et al. 1991).”
MethodSelf-citationBergström, M., Nordberg, A. K., Lunell, E., Antoni, G., & Långström, B. (1995) · Clinical Pharmacology & Therapeutics · doi:10.1016/0009-9236(95)90156-6 · Cited by 105 · cited 2×
“The term “inhaler” is somewhat of a misnomer, in that nicotine in the vapor phase rapidly deposits in the mouth, and very little is inhaled into the lungs (Bergstrom et al. 1995).”
BackgroundNicotine physical dependence and tolerance in the mouse following chronic oral administration
Grabus, S. D., Martin, B. R., Batman, A. M., Tyndale, R. F., Sellers, E. M., & Damaj, M. I. (2004) · Psychopharmacology · doi:10.1007/s00213-004-2007-3 · Cited by 105 · cited 1×
“Chronic oral administration has also been used successfully to demonstrate dependence (withdrawal) and tolerance (200 μg ml for 14–28 days and 50–200 μg ml for 42 days, respectively; Grabus et al. 2005), as well as alteration in signaling pathways (Brunzell et al.”
MethodSelf-citationIndividual differences in nicotine intake per cigarette.
Patterson, F., Benowitz, N. L., Shields, P. G., Kaufmann, V., Jepson, C., Wileyto, P., Kucharski, S., & Lerman, C. E. (2003) · PubMed · Cited by 104
Self-citationKlein, L. C., Stine, M. M., Vandenbergh, D. J., Whetzel, C. A., & Kamens, H. M. (2004) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2004.01.005 · Cited by 103 · cited 1×
“Consumption varies with sex and age, with adolescent female mice drinking higher concentrations of nicotine and consuming more (Meliska et al. 1995; Klein et al. 2004).”
BackgroundBuccafusco, J. J., Jackson, W. J., Terry, A. V., Marsh, K. C., Decker, M. W., & Arnerić, S. P. (1995) · Psychopharmacology · doi:10.1007/bf02311172 · Cited by 102 · cited 3×
“In this procedure, the optimal dose for each subject is identified in an initial dose study, followed by hypothesis testing with a dose range centered around this individual optimum (Buccafusco and Jackson 1991; Buccafusco et al. 1999).”
BackgroundInfluentialSelf-citationSkjei, K. L., & Markou, A. (2003) · Psychopharmacology · doi:10.1007/s00213-003-1414-1 · Cited by 101 · cited 3×
“16 mg kg day nicotine for 6 days induces both the somatic and the affective aspects of nicotine withdrawal indicative of dependence that emerge approximately 6 h after cessation of nicotine administration and that persist for approximately 2–3 days (Malin et al. 1997, 1998; Skjei and Markou 2003).”
BackgroundSelf-citationDiscrimination and self-administration of nicotine by inbred strains of mice
Stolerman, I. P., Naylor, C. G., Elmer, G. I., & Goldberg, S. R. (1999) · Psychopharmacology · doi:10.1007/s002130050837 · Cited by 100 · cited 2×
“1 mg kg is reinforcing in C57Bl/6J mice with jugular catheter administration and lever pressing as the required operant response (Stolerman et al. 1999).”
BackgroundSelf-citationHan, Z., Zoli, M., Cardona, A., Bourgeois, J., Changeux, J., & Le Novère, N. (2003) · Journal of Comparative Neurology · doi:10.1002/cne.10659 · Cited by 100 · cited 2×
“However, the larger distribution of cortical αbungarotoxin binding sites implicates a greater role of α7 receptors in these regions, compared to rodents (Han et al. 2003).”
Background125I-α-Conotoxin MII Identifies a Novel Nicotinic Acetylcholine Receptor Population in Mouse Brain
Whiteaker, P., McIntosh, J. M., Luo, S., Collins, A. C., & Marks, M. J. (2000) · Molecular Pharmacology · doi:10.1016/s0026-895x(24)26500-7 · Cited by 100 · cited 3×
“Investigators are referred to additional resources (e.g., Benowitz 1998; Tyndale and Sellers 2001; Whiteaker et al. 2000a,b) and a recent comprehensive review (Hukkanen et al. 2005) for specific details and additional references on nicotine pharmacokinetics and pharmacodynamics.”
Self-citationJones, H. E., Garrett, B. E., & Griffiths, R. R. (1999) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)37941-8 · Cited by 98 · cited 1×
“These subjects often report intense aversive effects, as well as pleasurable stimulant effects not unlike those of cocaine (Jones et al. 1999; Harvey et al. 2004).”
BackgroundCorrigall, W. A., Coen, K. M., Zhang, J., & Adamson, L. K. (2001) · Psychopharmacology · doi:10.1007/s002130100869 · Cited by 98
Pharmacokinetics, metabolism, and pharmacodynamics of nicotine
Benowitz, N. L., Porchet, H., & Jacob, P. (1990) · Nicotine Psychopharmacology · doi:10.1093/oso/9780192616142.003.0004 · Cited by 97
Self-citationPharmacokinetic Considerations in Understanding Nicotine Dependence
Benowitz, N. L. (2007) · Novartis Foundation Symposia · doi:10.1002/9780470513965.ch11 · Cited by 96 · cited 1×
“, mini-osmopump, chewing tobacco, drinking water, or NRTs, do not deliver a nicotine bolus rapidly to the brain (Benowitz 1990).”
BackgroundSelf-citationCarboni, E., Bortone, L., Giua, C., & Di Chiara, G. (2000) · Drug and Alcohol Dependence · doi:10.1016/s0376-8716(99)00064-2 · Cited by 96
Gotoh, O. (1998) · Molecular Biology and Evolution · doi:10.1093/oxfordjournals.molbev.a025872 · Cited by 96 · cited 1×
“elegans genome contains at least 60 putative CYP450 genes (Gotoh 1998); however, a clear CYP2A6 homolog or coumarin 7-hydroxylase encoding gene has not been identified.”
BackgroundQuik, M., Vailati, S., Bordia, T., Kulak, J. M., Fan, H., McIntosh, J. M., Clementi, F., & Gotti, C. (2004) · Molecular Pharmacology · doi:10.1124/mol.104.006015 · Cited by 96 · cited 1×
“The transcripts for the α2 through α7 and β2 through β4 nAChR subunits have been identified and expressed in nonhuman primate neuronal tissues, with numerous receptor subtypes present in multiple brain regions (Cimino et al. 1992; Han et al. 2000, 2003; Quik 2004; Quik et al. 2000, 2001, 2005).”
BackgroundSelf-citationControl of behavior by intravenous nicotine injections in laboratory animals
Goldberg, S. R., Spealman, R. D., Risner, M. E., & Henningfield, J. E. (1983) · Pharmacology Biochemistry and Behavior · doi:10.1016/0091-3057(83)90408-2 · Cited by 96 · cited 1×
“infusion has been the focus of a number of studies investigating reinforcement in squirrel monkeys because of the advantage that episodic selfadministration more closely resembles human smoking behavior (Goldberg and Spealman 1982; Goldberg et al. 1983; Henningfield and Goldberg 1983).”
BackgroundSvoboda, K. R., Vijayaraghavan, S., & Tanguay, R. L. (2002) · Journal of Neuroscience · doi:10.1523/jneurosci.22-24-10731.2002 · Cited by 96 · cited 3×
“Chronic exposure of zebrafish embryos to 33 μM nicotine (Svoboda et al. 2002), starting at 22 hpf, does not elicit immediate morphological abnormalities, but by 66 hpf embryos are 5% shorter than controls.”
BackgroundInfluentialStructure and Organization of the DrosophilaCholinergic Locus
Kitamoto, T., Wang, W., & Salvaterra, P. M. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.5.2706 · Cited by 94
Regional variation in the effects of nicotine on catecholamine overflow in rat brain
Benwell, M. E. M., & Balfour, D. J. K. (1997) · European Journal of Pharmacology · doi:10.1016/s0014-2999(97)00101-5 · Cited by 94
Self-citationPharmacokinetics of nicotine in healthy elderly people
Molander, L. (2001) · Clinical Pharmacology & Therapeutics · doi:10.1067/mcp.2001.113181 · Cited by 94 · cited 1×
“Total nicotine clearance is 23% slower in the elderly (age, 65–76 years) adult smokers compared to younger (age, 22–43 years) smokers (Molander et al. 2001), presumably due to a number of factors, such as lower CYP2A6-mediated metabolism, reduced liver blood flow, and slowed renal clearance.”
BackgroundLeSage, M. G., Keyler, D. E., Shoeman, D. W., Raphael, D. E., Collins, G., & Pentel, P. R. (2002) · Pharmacology Biochemistry and Behavior · doi:10.1016/s0091-3057(01)00775-4 · Cited by 94
Extinguishing the rewarding value of smoke cues: Pharmacological and behavioral treatments
Rose, J., & Behm, F. (2004) · Nicotine & Tobacco Research · doi:10.1080/14622200410001696501 · Cited by 94 · cited 1×
“In some studies, the design may entail administration of nicotine while subjects continue to smoke cigarettes (Rose and Behm 2004).”
BackgroundSelf-citationAn analysis of some discriminative properties of d-amphetamine
Kuhn, D. M., Appel, J. B., & Greenberg, I. (1974) · Psychopharmacology · doi:10.1007/bf00421458 · Cited by 94 · cited 1×
“A tandem variable interval and fixed ratio schedule (Kuhn et al. 1974) has some of the advantages of both VI and FR schedules: acquisition is almost as fast as with FR schedules, and data can be obtained by means of lengthy extinction tests, which is not the case when simple FR schedules are used (Stolerman 1989).”
MethodPlasma nicotine and cotinine levels following intravenous nicotine self-administration in rats
Shoaib, M., & Stolerman, I. P. (1999) · Psychopharmacology · doi:10.1007/s002130050954 · Cited by 94 · cited 1×
“While this pattern indicates that animals titrate their behavior to attain an optimized or preferred overall level of exposure, this titration is, at best, incomplete and higher unit doses can elicit substantially greater daily nicotine intake in individual rats (Donny et al. 1995, 2000; Shoaib and Stolerman 1999; Sho…”
BackgroundSelf-citationExposure of the Fetus, Neonate, and Nursed Infant to Nicotine and Cotinine from Maternal Smoking
(1984) · New England Journal of Medicine · doi:10.1056/nejm198409063111014 · Cited by 93 · cited 4×
“9 (Luck and Nau 1984).”
BackgroundInfluentialBogue, C. W., Ganea, G. R., Sturm, E., Iannucci, R., & Jacobs, H. C. (2000) · Developmental Dynamics · doi:10.1002/1097-0177(2000)9999:9999<::aid-dvdy1059>3.0.co;2-# · Cited by 93
Molecular and Genetic Approaches to Neurotransmitter and Neuromodulator Systems in Drosophila
Restifo, L. L., & White, K. (1990) · Advances in insect physiology · doi:10.1016/s0065-2806(08)60006-5 · Cited by 92 · cited 1×
“Finally, acetylcholinesterase (AChE), the enzyme that hydrolyzes acetylcholine, is encoded by a single locus in flies and multiple mutant alleles exist (Restifo and White 1990).”
BackgroundBrazell, M. P., Mitchell, S. N., & Gray, J. A. (1991) · Neuropharmacology · doi:10.1016/0028-3908(91)90116-s · Cited by 92
Drosophila acetylcholinesterase: Mechanisms of resistance to organophosphates
Fournier, D., Mutero, A., Pralavorio, M., & Bride, J.-M. (1993) · Chemico-Biological Interactions · doi:10.1016/0009-2797(93)90047-3 · Cited by 92 · cited 1×
“1980) and resistance to insecticides (Fournier et al. 1993; Pralavorio and Fournier 1992).”
Tsukada, H., Miyasato, K., Kakiuchi, T., Nishiyama, S., Harada, N., & Domino, E. F. (2002) · Synapse · doi:10.1002/syn.10102 · Cited by 91 · cited 2×
“In addition, higher doses [up to 0.3 mg kg −1 (100 μg kg −1 )] of nicotine over a 2-min period have been given, but these resulted in significant cardiovascular effects (Tsukada et al. 2002).”
BackgroundInfluentialCimino, M., Marini, P., Fornasari, D., Cattabeni, F., & Clementi, F. (1992) · Neuroscience · doi:10.1016/0306-4522(92)90472-e · Cited by 90 · cited 1×
“The transcripts for the α2 through α7 and β2 through β4 nAChR subunits have been identified and expressed in nonhuman primate neuronal tissues, with numerous receptor subtypes present in multiple brain regions (Cimino et al. 1992; Han et al. 2000, 2003; Quik 2004; Quik et al. 2000, 2001, 2005).”
BackgroundPersistence of chronic nicotine-induced cognitive facilitation
Levin, E. D., Briggs, S. J., Christopher, N. C., & Rose, J. E. (1992) · Behavioral and Neural Biology · doi:10.1016/0163-1047(92)90399-o · Cited by 90 · cited 1×
“It is interesting to note that tolerance to the enhancing effects of chronic nicotine administration on radial-arm maze choice accuracy does not develop and a lasting improvement after withdrawal is observed, even when there is no training during the nicotine treatment period (Levin et al. 1992).”
BackgroundSelf-citationOlale, F., Gerzanich, V., Kuryatov, A., Wang, F., & Lindstrom, J. (1997) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)37064-8 · Cited by 90
Fu, Y., Matta, S. G., James, T. J., & Sharp, B. M. (1998) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)37341-0 · Cited by 89
Self-citationDecker, M. W., Bannon, A. W., Curzon, P., Gunther, K. L., Brioni, J. D., Holladay, M. W., Lin, N.-H., Li, Y., Daanen, J. F., Buccafusco, J. J., et al. (1997) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)37015-6 · Cited by 88
Self-citationNicotine elevates rat plasma ACTH by a central mechanism.
Matta, S. G., Beyer, H. S., McAllen, K. M., & Sharp, B. M. (1987) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)39223-2 · Cited by 87 · cited 1×
“) to drugnaïve rats have been shown to increase plasma adrenocorticotropic hormone (ACTH) (Matta et al. 1987) and, subsequently, plasma corticosterone levels (Benwell and Balfour 1979; Caggiula et al.”
BackgroundSelf-citationLeSage, M. G., Keyler, D. E., Collins, G., & Pentel, P. R. (2003) · Psychopharmacology · doi:10.1007/s00213-003-1539-2 · Cited by 87 · cited 1×
“relatively unlimited daily nicotine intake in regular smokers (Brower et al. 2002; DeNoble and Mele 2006; Fu et al. 2001; Kenny and Markou 2006; LeSage et al. 2003; Paterson and Markou 2004; Valentine et al. 1997).”
BackgroundSpealman, R. D., & Goldberg, S. R. (1982) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)33347-1 · Cited by 87
Blokhina, E. A., Кашкин, В. А., Zvartau, E. E., Danysz, W., & Bespalov, A. (2004) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2004.07.005 · Cited by 85 · cited 1×
“05 mg kg per injection), while lower or higher concentrations are not reinforcing (Blokhina et al. 2005; Martellota et al. 1995; Rasmussen and Swedberg 1998; Semenova et al. 2003).”
BackgroundWaggoner, L. E., Dickinson, K., Poole, D. S., Tabuse, Y., Miwa, J., & Schafer, W. R. (2000) · Journal of Neuroscience · doi:10.1523/jneurosci.20-23-08802.2000 · Cited by 85 · cited 5×
“In an UNC-29::GFP chimera, chronic nicotine exposure leads to a slow reduction in the abundance of UNC-29 in the vulval muscle cells, requiring 12–24 h for maximal effect (Waggoner et al. 2000).”
BackgroundMethodInfluentialSelf-citationNguyen, H. N., Rasmussen, B. A., & Perry, D. C. (2004) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2004.02482.x · Cited by 83 · cited 1×
“This is supported by the regionally specific upregulation of active (epibatidine-stimulated 86 Rb efflux) nAChRs with chronic nicotine exposure via osmopump (Nguyen et al. 2004).”
BackgroundNicotine metabolism: the impact of CYP2A6 on estimates of additive genetic influence
Swan, G. E., Benowitz, N. L., Lessov, C. N., Jacob, P., Tyndale, R. F., & Wilhelmsen, K. (2005) · Pharmacogenetics and Genomics · doi:10.1097/01213011-200502000-00007 · Cited by 83 · cited 1×
“Even among individuals without identified polymorphisms, there is a wide variability in the rate of nicotine metabolism (Swan et al. 2005).”
BackgroundSelf-citationMarks, M. J., Rowell, P. P., Cao, J., Grady, S. R., McCallum, S. E., & Collins, A. C. (2004) · Neuropharmacology · doi:10.1016/j.neuropharm.2004.02.009 · Cited by 83
Self-citationLevin, E. D., Kim, P. M., & Meray, R. (1996) · Psychopharmacology · doi:10.1007/bf02805971 · Cited by 82 · cited 3×
“Adults with attention deficit hyperactivity disorder (ADHD) (Levin et al. 1996b) and normal young adults (Levin et al. 1998), administered with a low-dose 7-mg patch for a single morning session, show significant improvement in attentional performance with only a few instances of short-term (a few hours) nausea, heada…”
BackgroundSelf-citationRat strain differences in nicotine self-administration using an unlimited access paradigm
Brower, V. G., Fu, Y., Matta, S. G., & Sharp, B. M. (2002) · Brain Research · doi:10.1016/s0006-8993(01)03375-3 · Cited by 82 · cited 3×
“relatively unlimited daily nicotine intake in regular smokers (Brower et al. 2002; DeNoble and Mele 2006; Fu et al. 2001; Kenny and Markou 2006; LeSage et al. 2003; Paterson and Markou 2004; Valentine et al. 1997).”
BackgroundSelf-citationApparent absence of nicotine-induced conditioned place preference in rats
Clarke, P. B. S., & Fibiger, H. C. (1987) · Psychopharmacology · doi:10.1007/bf00215484 · Cited by 82
Pharmacologic and sensorimotor components of satiation in cigarette smoking
Rose, J. E., Behm, F. M., Westman, E. C., Bates, J. E., & Salley, A. (2003) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2003.07.002 · Cited by 81 · cited 3×
“In contrast, when nicotine is administered in puff-sized boli (0.1 mg kg −1 per injection), the subjective rewarding and aversive effects are minimal (Rose et al. 2003a–c).”
BackgroundMethodInfluentialSelf-citationSlotkin, T. A., Pinkerton, K. E., Auman, J. T., Qiao, D., & Seidler, F. J. (2002) · Developmental Brain Research · doi:10.1016/s0165-3806(02)00281-x · Cited by 81 · cited 1×
“for 5 days per week for about 1 month (Slotkin et al. 2002).”
BackgroundOral administration of nicotine: Its uptake and distribution after chronic administration to mice
Rowell, P. P., Hurst, H. E., Marlowe, C., & Bennett, B. D. (1983) · Journal of Pharmacological Methods · doi:10.1016/0160-5402(83)90064-5 · Cited by 81
Adolescent Development of Forebrain Stimulant Responsiveness: Insights from Animal Studies
LESLIE, F. M., LOUGHLIN, S. E., WANG, R., PEREZ, L., LOTFIPOUR, S., & BELLUZZIA, J. D. (2004) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1308.018 · Cited by 81 · cited 1×
“2003a), and age of onset of nicotine self-administration (Leslie et al. 2004).”
BackgroundRole of the locus coeruleus in the noradrenergic response to a systemic administration of nicotine
Mitchell, S. N. (1993) · Neuropharmacology · doi:10.1016/0028-3908(93)90058-b · Cited by 81
Schuurmans, M. M., Diacon, A. H., Van Biljon, X., & Bolliger, C. T. (2004) · Addiction · doi:10.1111/j.1360-0443.2004.00711.x · Cited by 81 · cited 2×
“…skin patches or combinations of two or more forms of NRT, have found no evidence of serious toxic effects (Benowitz 2004; Benowitz et al. 1998; Schuurmans et al. 2004; Working Group for the Study of Transdermal Nicotine in Patients with Coronary Artery Disease 1994), indicating that smokers…”
BackgroundCloning and expression of zebrafish neuronal nicotinic acetylcholine receptors
Zirger, J. M., Beattie, C. E., McKay, D. B., & Boyd, R. T. (2003) · Gene Expression Patterns · doi:10.1016/s1567-133x(03)00126-1 · Cited by 81
Self-citationDose-response analysis of nicotine tolerance and receptor changes in two inbred mouse strains.
Marks, M. J., Stitzel, J. A., & Collins, A. C. (1986) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)23600-x · Cited by 80 · cited 1×
“Nicotine increases receptor binding in a dose-dependent manner (Marks et al. 1986a,b; Breese et al. 1997) and, perhaps, receptor sensitivity as well (Buisson and Bertrand 2002).”
BackgroundSelf-citationA genetic comparison of behavioral actions of ethanol and nicotine in the mirrored chamber
Cao, W., Burkholder, T., Wilkins, L. H., & Collins, A. C. (1993) · Pharmacology Biochemistry and Behavior · doi:10.1016/0091-3057(93)90124-c · Cited by 79
Self-citationHow complex is the nicotinic receptor system of insects?
Gundelfinger, E. D. (1992) · Trends in Neurosciences · doi:10.1016/0166-2236(92)90035-7 · Cited by 78 · cited 1×
“Homologybased cloning and genome analysis has identified ten receptors with homology to mammalian nAChRs in Drosophila (Gundelfinger 1992; Littleton and Ganetzky 2000).”
BackgroundThe Zebrafish Motility Mutant twitch once Reveals New Roles for Rapsyn in Synaptic Function
Ono, F., Shcherbatko, A., Higashijima, S.-I., Mandel, G., & Brehm, P. (2002) · The Journal of Neuroscience · doi:10.1523/jneurosci.22-15-06491.2002 · Cited by 78
Tolerance to nicotine following chronic treatment by injections: a potential role for corticosterone
Pauly, J. R., Grun, E. U., & Collins, A. C. (1992) · Psychopharmacology · doi:10.1007/bf02245282 · Cited by 77
Self-citationSotaniemi, E., Rautio, A., Backstrom, M., Arvela, P., & Pelkonen, O. (1995) · British Journal of Clinical Pharmacology · doi:10.1111/j.1365-2125.1995.tb04412.x · Cited by 74 · cited 2×
“While many hepatic disorders, such as alcoholic liver disease (Sotaniemi et al. 1995) and hepatitis A (Pasanen et al. 1997), are associated with reduced CYP2A6-mediated metabolism, liver fluke parasitic infection actually induces it (Satarug et al. 1996).”
BackgroundSharp, B. M. (1993) · Endocrinology · doi:10.1210/en.133.1.11 · Cited by 74 · cited 2×
“…neurotransmitter responses, such as increases in dopamine release in the nucleus accumbens (Balfour 2004; Fu et al. 2000a) or elevated norepinephrine secretion in the paraventricular nucleus (Fu et al. 2001; Sharp and Matta 1993), depend upon sufficient nicotine reaching the brain quickly.”
BackgroundSelf-citationSatarug, S., Lang, M. A., Yongvanit, P., Sithithaworn, P., Mairiang, E., Mairiang, P., Pelkonen, P., Bartsch, H., & Haswell, M. (1996) · PubMed · Cited by 74
Nicotine metabolism by rat hepatic cytochrome P450s
Nakayama, H., Okuda, H., Nakashima, T., Imaoka, S., & Funae, Y. (1993) · Biochemical Pharmacology · doi:10.1016/0006-2952(93)90238-r · Cited by 73
4 Genetics of Biological Rhythms in Drosophila
Hall, J. C. (1998) · Advances in genetics · doi:10.1016/s0065-2660(08)60143-1 · Cited by 72
A description of the nicotine stimulus and tests of its generalization to amphetamine
Chance, W. T., Murfin, D., Krynock, G. M., & Rosecrans, J. A. (1977) · Psychopharmacology · doi:10.1007/bf00432812 · Cited by 72
Social isolation modifies nicotine's effects in animal tests of anxiety
Cheeta, S., Irvine, E., & File, S. E. (2001) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0703991 · Cited by 71
Reinforcing Effects of Nicotinic Compounds Intravenous Self-administration in Drug-Naive Mice
Rasmussen, T. (1998) · Pharmacology Biochemistry and Behavior · doi:10.1016/s0091-3057(98)00003-3 · Cited by 71
King, S. L., Caldarone, B. J., & Picciotto, M. R. (2004) · Neuropharmacology · doi:10.1016/j.neuropharm.2004.06.024 · Cited by 70 · cited 2×
“Despite this, nicotine delivered via these latter routes can lead to conditioned place preference (CPP) (Le Foll and Goldberg 2005a,b; Risinger and Oakes 1995), as well as dopamine-dependent locomotor activation (King et al. 2004; Sparks and Pauly 1999).”
BackgroundSelf-citationEffects of nicotine and mecamylamine on cognition in rhesus monkeys
Katner, S. N., Davis, S. A., Kirsten, A. J., & Taffe, M. A. (2004) · Psychopharmacology · doi:10.1007/s00213-004-1804-z · Cited by 70 · cited 2×
“…mulatta, Macaca fascicularis, and Macaca nemestrina) with doses generally ranging from 0.001 to 0.056 mg kg −1 (0.3–18 μg kg −1 ) (Buccafusco and Jackson 1991; Buccafusco et al. 1995, 1999; Elrod et al. 1988; Katner et al. 2004; Prendergast et al. 1997; Terry et al. 1993; Witte et al. 1997).”
BackgroundInfluentialEffects of nicotine and stress on locomotion in Sprague–Dawley and Long–Evans male and female rats
Faraday, M. M., O’Donoghue, V. A., & Grunberg, N. E. (2002) · Pharmacology Biochemistry and Behavior · doi:10.1016/s0091-3057(02)00999-1 · Cited by 69 · cited 2×
“1998), and while the range of doses is comparable between genders, details of the dose–response functions relating nicotine to activity can vary depending on interactions between strain, developmental stage, and the activity measurement used (Elliott et al. 2004; Faraday et al. 2003).”
BackgroundLavenex, P., Steele, M. A., & Jacobs, L. F. (2000) · The Journal of Comparative Neurology · doi:10.1002/1096-9861(20000911)425:1<97::aid-cne9>3.0.co;2-n · Cited by 69
Self-citationThe potential role of cotinine in the cognitive and neuroprotective actions of nicotine
Buccafusco, J. J., & Terry, A. V. (2003) · Life Sciences · doi:10.1016/s0024-3205(03)00226-1 · Cited by 68
Self-citationInhibition of cigarette smoking by orally administered nicotine
Jarvik, M. E., Glick, S. D., & Nakamura, R. K. (1970) · Clinical Pharmacology & Therapeutics · doi:10.1002/cpt1970114574 · Cited by 68 · cited 1×
“Although some early studies administered nicotine orally (Jarvik et al. 1970), this route has not been widely used because of first-pass liver metabolism (Benowitz et al. 1990; see also " Rate of metabolism " ) and because it was generally believed that attempts to overcome this first-pass loss…”
The levamisole receptor, a cholinergic receptor of the nematode Caenorhabditis elegans.
Lewis, J. A., Fleming, J. T., McLafferty, S., Murphy, H. S., & Wu, C. (1987) · Molecular Pharmacology · doi:10.1016/s0026-895x(25)10353-2 · Cited by 67 · cited 1×
“2000), as well as lev-9 and lev-11 (Lewis et al. 1987).”
Mammalian metabolism of plant xenobiotics:
Millburn, P. (1979) · Phytochemistry · doi:10.1016/0031-9422(79)83046-0 · Cited by 67
Fu, Y., Matta, S. G., Brower, V. G., & Sharp, B. M. (2001) · The Journal of Neuroscience · doi:10.1523/jneurosci.21-22-08979.2001 · Cited by 66 · cited 1×
“…neurotransmitter responses, such as increases in dopamine release in the nucleus accumbens (Balfour 2004; Fu et al. 2000a) or elevated norepinephrine secretion in the paraventricular nucleus (Fu et al. 2001; Sharp and Matta 1993), depend upon sufficient nicotine reaching the brain quickly.”
BackgroundSelf-citationConditioned tolerance to the anorectic and corticosterone-elevating effects of nicotine
Caggiula, A. R., Epstein, L. H., Antelman, S. M., Saylor, S., Perkins, K. A., Knopf, S., & Stiller, R. L. (1991) · Pharmacology Biochemistry and Behavior · doi:10.1016/0091-3057(91)90319-w · Cited by 66
Self-citationSastry, B. V. R., Chance, M. B., Hemontolor, M. E., & Goddijn-Wessel, T. A. W. (1998) · Pharmacology · doi:10.1159/000028231 · Cited by 66 · cited 1×
“In addition, the high lipid content of breast milk and placenta tends to sequester nicotine and cotinine (Sastry et al. 1998).”
BackgroundKane, V. B., Fu, Y., Matta, S. G., & Sharp, B. M. (2004) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.103.059899 · Cited by 66 · cited 1×
“In utero exposure to 3 mg kg day results in a gender-dependent reduction in nicotine-stimulated dopamine release in the nucleus accumbens (Kane et al. 2003).”
BackgroundSelf-citationNicotine-Induced Dopamine Release in Primates Measured with [11C]Raclopride PET
Marenco, S., Carson, R. E., Berman, K. F., Herscovitch, P., & Weinberger, D. R. (2003) · Neuropsychopharmacology · doi:10.1038/sj.npp.1300287 · Cited by 66 · cited 2×
“Baboons (Papio) and rhesus monkeys (M. mulatta) have been given nicotine doses ranging from 5 to 40 μg kg −1 (Ding et al. 2000; Fowler et al. 1998; Valette et al. 2003) or 0.01–0.065 mg kg −1 (3–20 μg kg −1 ) (Marenco et al. 2004).”
InfluentialInfluence of Gender and Sex Hormones on Nicotine Acute Pharmacological Effects in Mice
Damaj, M. I. (2001) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)29673-7 · Cited by 66
Self-citationMaintenance and suppression of behavior by intravenous nicotine injections in squirrel monkeys.
Goldberg, & Rd, S. (1982) · PubMed · Cited by 66
Aizawa, H., Kobayashi, Y., Yamamoto, M., & Isa, T. (1999) · Journal of Neurophysiology · doi:10.1152/jn.1999.82.3.1642 · Cited by 66 · cited 1×
“The primary mode of acute nicotine treatment is via intramuscular (i.m.) or i.v. injection, although nicotine has also been delivered by intracranial (i.c.) injection (Aizawa et al. 1999) (see Table 1).”
BackgroundSchneider, J. S., Van Velson, M., Menzaghi, F., & Lloyd, G. K. (1998) · Annals of Neurology · doi:10.1002/ana.410430308 · Cited by 65
Seidler, F. J., & Slotkin, T. A. (1990) · Brain Research Bulletin · doi:10.1016/0361-9230(90)90200-j · Cited by 64 · cited 2×
“In gestational nicotine exposure studies, the use of the osmotic minipumps eliminates the fetal hypoxic consequence of uteroplacental vasoconstriction resulting from repeated acute injections (Seidler and Slotkin 1990).”
BackgroundSchoedel, K. A., Sellers, E. M., Palmour, R., & Tyndale, R. F. (2003) · Molecular Pharmacology · doi:10.1124/mol.63.1.96 · Cited by 64
Self-citationFu, Y., Matta, S. G., Gao, W., & Sharp, B. M. (2000) · Neuroscience · doi:10.1016/s0306-4522(00)00371-7 · Cited by 64 · cited 2×
“Thus, some nicotinestimulated neurotransmitter responses, such as increases in dopamine release in the nucleus accumbens (Balfour 2004; Fu et al. 2000a) or elevated norepinephrine secretion in the paraventricular nucleus (Fu et al. 2001; Sharp and Matta 1993), depend upon sufficient nicotine…”
BackgroundSelf-citationSchneider, J. S., Pope‐Coleman, A., Van Velson, M., Menzaghi, F., & Kenneth Lloyd, G. (1998) · Movement Disorders · doi:10.1002/mds.870130405 · Cited by 63
Attentional effects of nicotine and amphetamine in rats at different levels of motivation
Bizarro, L., & Stolerman, I. P. (2003) · Psychopharmacology · doi:10.1007/s00213-003-1543-6 · Cited by 63 · cited 1×
“These nicotine-induced improvements in attentional accuracy are not attributable merely to an increasing motivation to perform the task because increasing food motivation results in a different array of changes on the task (Bizzaro and Stolerman 2003).”
BackgroundSelf-citationPauly, J. R., Grun, E. U., & Collins, A. C. (1990) · Psychopharmacology · doi:10.1007/bf02244047 · Cited by 62 · cited 1×
“1992) and the induction of tolerance after implantation of corticosterone pellets (Pauly et al. 1990).”
BackgroundSelf-citationNeuronal‐type nicotinic receptors in human neuroblastoma and small‐cell lung carcinoma cell lines
Tarroni, P., Rubboli, F., Chini, B., Zwart, R., Oortgiesen, M., Sher, E., & Clementi, F. (1992) · FEBS Letters · doi:10.1016/0014-5793(92)81411-e · Cited by 62
Samson, H. H., Tolliver, G. A., Pfeffer, A. O., Sadeghi, K. G., & Haraguchi, M. (1988) · Alcohol · doi:10.1016/0741-8329(88)90024-9 · Cited by 61 · cited 1×
“2002) and these solutions are not particularly palatable, frequently requiring pre-training periods in which daily nicotine is combined with receding doses of saccharin over weeks of access, akin to the sucrose-fade method for alcohol (Samson et al. 1988) (also see “Nicotine in drinking water” and “Nicotine in drinkin…”
BackgroundInfluence of Sex and Female Hormones on Nicotine-Induced Changes in Locomotor Activity in Rats
Kanýt, L., Stolerman, I. P., Chandler, C. J., Saigusa, T., & Pöğün, Ş. (1999) · Pharmacology Biochemistry and Behavior · doi:10.1016/s0091-3057(98)00140-3 · Cited by 61 · cited 1×
“Nicotine has similar effects on the locomotor activity of female rats (Kanyt et al. 1998), and while the range of doses is comparable between genders, details of the dose–response functions relating nicotine to activity can vary depending on interactions between strain, developmental stage, and the activity measuremen…”
MethodSelf-citationKim, J., Poole, D. S., Waggoner, L. E., Kempf, A., Ramirez, D. S., Treschow, P. A., & Schafer, W. R. (2001) · Genetics · doi:10.1093/genetics/157.4.1599 · Cited by 60
Self-citationSepich, D. S., Wegner, J., O'Shea, S., & Westerfield, M. (1998) · Genetics · doi:10.1093/genetics/148.1.361 · Cited by 60
Valentine, J. D. (1996) · Endocrinology · doi:10.1210/en.137.2.622 · Cited by 60
Self-citationEffects of Nicotine Vary Across Two Auditory Evoked Potentials in the Mouse
Metzger, K. L., Maxwell, C. R., Liang, Y., & Siegel, S. J. (2006) · Biological Psychiatry · doi:10.1016/j.biopsych.2005.12.011 · Cited by 59
Scopolamine reversal of nicotine enhanced delayed matching-to-sample performance in monkeys
Terry, A. V., Buccafusco, J. J., & Jackson, W. J. (1993) · Pharmacology Biochemistry and Behavior · doi:10.1016/0091-3057(93)90141-f · Cited by 59
Self-citationHudzik, T. J., & Wenger, G. R. (1993) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)38114-0 · Cited by 58 · cited 1×
“These studies have been done in squirrel monkeys (Saimiri sciureus) with doses of nicotine from 0.1 to 1.0 mg kg −1 (32–325 μg kg −1 ) (Hudzik and Wenger 1993) and in macaques (Macaca mulatta, Macaca fascicularis, and Macaca nemestrina) with doses generally ranging from 0.001 to 0.056 mg kg −1…”
BackgroundInfluentialNicotinic acetylcholine receptors of the central nervous system of Drosophila
Gundelfinger, E. D., & Hess, N. (1992) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/0167-4889(92)90150-a · Cited by 58 · cited 1×
“However, the expression of several subunits and the binding of alphabungarotoxin has been shown to be nervous system specific (Gundelfinger and Hess 1992).”
BackgroundKassiou, M., Eberl, S., Meikle, S. R., Birrell, A., Constable, C., Fulham, M. J., Wong, D. F., & Musachio, J. L. (2001) · Nuclear Medicine and Biology · doi:10.1016/s0969-8051(00)00206-7 · Cited by 58 · cited 1×
“In that study, in vivo upregulation of nicotinic receptors was also demonstrated using SPECT (Kassiou et al. 2001).”
MethodMeyer, E. L., Xiao, Y., & Kellar, K. J. (2001) · PubMed · Cited by 58
Iyaniwura, T., Wright, A., & Balfour, D. (2001) · Psychopharmacology · doi:10.1007/s002130100852 · Cited by 57 · cited 1×
“…that studies suggest that some responses, such as the increase in dopamine overflow in the nucleus accumbens dialysate, may persist for up to an hour after an acute nicotine injection (Benwell and Balfour 1992; Fu et al. 2000b; Imperato et al. 1986; Iyaniwura et al. 2001; Nisell et al. 1994).”
BackgroundSelf-citationIsradipine inhibits nicotine intravenous self-administration in drug-naive mice
Martellotta, M. C., Kuzmin, A. V., Zvartau, E. E., Cossu, G., Gessa, G. L., & Fratta, W. (1995) · Pharmacology Biochemistry and Behavior · doi:10.1016/0091-3057(95)00096-f · Cited by 57
Influence of kinetics of nicotine administration on tolerance development and receptor levels
Marks, M. J., Stitzel, J. A., & Collins, A. C. (1987) · Pharmacology Biochemistry and Behavior · doi:10.1016/0091-3057(87)90355-8 · Cited by 56 · cited 1×
“In addition, nicotine dose and the kinetics of administration can be readily adjusted (Marks et al. 1987) with precise control of both the timing of treatment initiation and of cessation.”
BackgroundSelf-citationEffects of chronic nicotine administration on the response and adaptation to stress
Benwell, M. E. M., & Balfour, D. J. K. (1982) · Psychopharmacology · doi:10.1007/bf00435271 · Cited by 56 · cited 1×
“…in animal studies (see " Acute nicotine treatment regimens " and " Repeated injection " ), because it not only alters general metabolism but also effects several nicotine-responsive neurotransmitter systems (Balfour 1991; Benwell and Balfour 1982; Matta et al. 1993, 1998; Takahashi et al. 2000).”
BackgroundSelf-citationKulak, J. M., McIntosh, J. M., & Quik, M. (2002) · Molecular Pharmacology · doi:10.1124/mol.61.1.230 · Cited by 56 · cited 1×
“Dihydro-β-erythroidine (DHβE) is more selective for the widespread α4β2* nAChRs (Mansvelder et al. 2002), whereas α-conotoxin MII is the preferred antagonist for nAChRs containing α6 or α3 subunits (Kulak et al. 2002; Whiteaker et al. 2000a, b), central to the mesocorticolimbic reward pathway.”
BackgroundSelf-citationBehavioral effects of nicotine: schedule-controlled responding by squirrel monkeys.
Spealman, R. D., Goldberg, S. R., & Gardner, M. L. (1981) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)32453-5 · Cited by 55 · cited 3×
“7–32 μg kg), although the higher doses have been linked to side effects such as vomiting (Goldberg et al. 1981; Spealman and Goldberg 1982; Spealman et al. 1981).”
BackgroundGrove, K. L., Sekhon, H. S., Brogan, R. S., Keller, J. A., Smith, M. S., & Spindel, E. R. (2001) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.86.11.8033 · Cited by 54 · cited 1×
“5 mg kg day (325 to 480 μg kg day) has been chronically infused into pregnant rhesus monkeys for 4 months (Grove et al. 2001; Sekhon et al. 1999).”
MethodShiffman, S., Dresler, C. M., & Rohay, J. M. (2004) · Addiction · doi:10.1111/j.1360-0443.2004.00576.x · Cited by 54 · cited 1×
“While chewing a piece of nicotine gum, nicotine levels increase gradually over 15–30 min, and approximately half of the content of the gum is absorbed, i.e., 1 mg from " 2 mg gum " and 2 mg from " 4 mg gum " (Benowitz et al. 1990; Shiffman et al. 2002, 2004 ).”
BackgroundPanagis, G., Hildebrand, B. E., Svensson, T. H., & Nomikos, G. G. (2000) · Synapse · doi:10.1002/(sici)1098-2396(200001)35:1<15::aid-syn3>3.0.co;2-c · Cited by 54 · cited 1×
“1992), as well as changes in neurotransmitter release in discrete brain sites (Carboni et al. 2000; Hildebrand et al. 1998, 1999; Hildebrand and Svensson 2000; Panagis et al. 2000) that are considered to underlie drug dependence processes.”
BackgroundStolerman, I. P. (1989) · Psychopharmacology · doi:10.1007/bf00443427 · Cited by 53
Self-citationPharmacological and null mutation approaches reveal nicotinic receptor diversity
Whiteaker, P., Marks, M. J., Grady, S. R., Lü, Y., Picciotto, M. R., Changeux, J., & Collins, A. C. (2000) · European Journal of Pharmacology · doi:10.1016/s0014-2999(00)00052-2 · Cited by 53 · cited 3×
“Investigators are referred to additional resources (e.g., Benowitz 1998; Tyndale and Sellers 2001; Whiteaker et al. 2000a,b) and a recent comprehensive review (Hukkanen et al. 2005) for specific details and additional references on nicotine pharmacokinetics and pharmacodynamics.”
BackgroundSelf-citationTashkin, D. P., Gliederer, F., Rose, J. E., Chang, P. C., Hui, K.-K. P., Yu, J. L., & Wu, T. (1991) · Pharmacology Biochemistry and Behavior · doi:10.1016/0091-3057(91)90377-e · Cited by 53 · cited 1×
“Several methods of controlling puff volume and inhalation volume have been devised, which can effectively regulate the dose of nicotine inhaled (Gilbert et al. 1989; Levin et al. 1989; Pomerleau et al. 1989; Rose et al. 1985; Tashkin et al. 1991).”
MethodSelf-citationHepatitis A impairs the function of human hepatic CYP2A6 in vivo
Pasanen, M., Rannala, Z., Tooming, A., Sotaniemi, E. A., Pelkonen, O., & Rautio, A. (1997) · Toxicology · doi:10.1016/s0300-483x(97)00119-4 · Cited by 53 · cited 2×
“1995) and hepatitis A (Pasanen et al. 1997), are associated with reduced CYP2A6-mediated metabolism, liver fluke parasitic infection actually induces it (Satarug et al.”
BackgroundMcCallum, S. E., Parameswaran, N., Bordia, T., McIntosh, J. M., Grady, S. R., & Quik, M. (2005) · Molecular Pharmacology · doi:10.1124/mol.105.012773 · Cited by 53 · cited 1×
“These nAChRs are functional at both the cellular and whole animal level, e.g., robust nicotine-evoked dopamine release has been identified in monkey striatal synaptosomes (McCallum et al. 2005, 2006).”
BackgroundSelf-citationVisualization of integral and peripheral cell surface proteins in live Caenorhabditis elegans
GOTTSCHALK, A. R., & Schafer, W. R. (2006) · Journal of Neuroscience Methods · doi:10.1016/j.jneumeth.2005.11.016 · Cited by 53 · cited 1×
“The overexpression of tagged molecules allows for visualization of changes in gene expression levels and subcellular localization of proteins in response to nicotine (Gottschalk and Schafer 2006; Waggoner et al. 2000).”
BackgroundSelf-citationGoldberg, S. R., & Spealman, R. D. (1983) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)33475-0 · Cited by 53 · cited 2×
“Jugular infusion of 0.009–0.03 mg kg −1 [3–10 μg kg −1 ] via a catheter has also been used (Goldberg and Spealman 1983), although this does invoke the complications associated with surgical implantations.”
MethodInfluential(1994) · Archives of Internal Medicine · doi:10.1001/archinte.154.9.989 · Cited by 53
Malin, D. H., Lake, J. R., Upchurch, T. P., Shenoi, M., Rajan, N., & Schweinle, W. E. (1998) · Pharmacology Biochemistry and Behavior · doi:10.1016/s0091-3057(98)00028-8 · Cited by 52 · cited 1×
“These somatic signs can also be induced by the administration of a variety of nAchR antagonists (Epping-Jordan et al. 1998; Hildebrand et al. 1997–1999; Malin et al. 1998; Watkins et al. 2000).”
BackgroundRisner, M. E., Goldberg, S. R., Prada, J. A., & Cone, E. J. (1985) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)23321-3 · Cited by 52
Blood, F. R., Amdur, M. O., & Hayes, W. J. (1972) · Cited by 51
Fu, Y. (1997) · Endocrinology · doi:10.1210/en.138.5.1935 · Cited by 51
Self-citationChromosomal localization of seven neuronal nicotinic acetylcholine receptor subunit genes in humans
Anand, R., & Lindstrom, J. M. (1992) · Genomics · doi:10.1016/0888-7543(92)90008-g · Cited by 50 · cited 1×
“1), human α4 (Anand and Lindstrom 1992), mouse α4 (Watanabe et al.”
Acute and chronic nicotine effects on measures of activity in rats: a multivariate analysis
Ksir, C. J. (1994) · Psychopharmacology · doi:10.1007/bf02244758 · Cited by 50 · cited 2×
“If animals are first habituated to the testing chamber, so that spontaneous locomotor behavior has largely subsided, a dose range of 100–500 μg kg is likely to produce only locomotor activation that also increases with repeated daily exposure (Ksir 1994).”
BackgroundHammond, D. K., Bjercke, R. J., Langone, J. J., & Strobel, H. W. (1991) · Drug Metabolism and Disposition · doi:10.1016/s0090-9556(25)08898-1 · Cited by 50 · cited 1×
“In addition, although the mouse CYP2A5 is a homolgue of human CYP2A6, in the rat, CYP1B1/2 is responsible for nicotine metabolism and CYP2A6 is inactive (Hammond et al. 1991; Nakayama et al. 1993).”
BackgroundAbsolute bioavailability of nicotine applied to different nasal regions
Johansson, C.-J., Olsson, P., Bende, M., Carlsson, T., & Gunnarsson, P. O. (1991) · European Journal of Clinical Pharmacology · doi:10.1007/bf00314989 · Cited by 49 · cited 1×
“The biovailability of nasal spray nicotine is approximately 50–75% (Benowitz et al. 1997; Johansson et al. 1991).”
BackgroundTechniques: fruit flies as models for neuropharmacological research
Manev, H., Dimitrijević, N., & Dzitoyeva, S. (2003) · Trends in Pharmacological Sciences · doi:10.1016/s0165-6147(02)00004-4 · Cited by 48 · cited 2×
“5–4 nmol injected into the abdomen of adult flies exhibits a dose–response relationship for viability, in that 1 nmol has no effect, but 2 and 4 nmol cause 30 and 100% lethality, respectively (Manev et al. 2003).”
BackgroundHall, J. C., Alahiotis, S., Strumpf, D. A., & White, K. (1980) · Genetics · doi:10.1093/genetics/96.4.939 · Cited by 46
The nicotine transdermal system
Gore, A. V., & Chien, Y. W. (1998) · Clinics in Dermatology · doi:10.1016/s0738-081x(98)00046-7 · Cited by 46 · cited 1×
“Nicoderm delivers a rapid initial dose of nicotine, resulting in peak levels within 4 h of administration, whereas the other patches generally require 6–9 h to reach peak levels (Gore and Chien 1998).”
BackgroundNicotine Abstinence Syndrome Precipitated by Central But Not Peripheral Hexamethonium
Malin, D. H., Lake, J. R., Schopen, C. K., Kirk, J. W., Sailer, E. E., Lawless, B. A., Upchurch, T. P., Shenoi, M., & Rajan, N. (1997) · Pharmacology Biochemistry and Behavior · doi:10.1016/s0091-3057(97)90006-x · Cited by 45
Measures of stimulus generalization in drug discrimination experiments
Stolerman, I. P. (1991) · Behavioural Pharmacology · doi:10.1097/00008877-199109000-00003 · Cited by 44
Self-citationThe influence of stress on psychopharmacological responses to nicotine
BALFOUR, D. J. K. (1991) · British Journal of Addiction · doi:10.1111/j.1360-0443.1991.tb01795.x · Cited by 44 · cited 2×
“Stress is an important environmental factor that may influence responses to nicotine, especially in animal studies (see “Acute nicotine treatment regimens” and “Repeated injection”), because it not only alters general metabolism but also effects several nicotine-responsive neurotransmitter systems (Balfour 1991; Benwe…”
BackgroundSelf-citationChronic Nicotinic Agonist and Antagonist Effects on T-maze Alternation
Levin, E. D., Christopher, N. C., & Briggs, S. J. (1997) · Physiology & Behavior · doi:10.1016/s0031-9384(96)00609-9 · Cited by 43 · cited 1×
“The 5 mg kg day nicotine dose does not improve performance in T-maze alternation, a task with considerable proactive interference (Levin et al. 1997).”
BackgroundSelf-citationEffects of deuterium oxide and temperature on heart rate in Drosophila melanogaster
White, L. A., Ringo, J. M., & Dowse, H. B. (1992) · Journal of Comparative Physiology B · doi:10.1007/bf00357535 · Cited by 43 · cited 1×
“The effect of direct nicotine injections on heart rate, measured using a microscope-based optical assay, is dose and age dependent (Johnson et al. 1997; White et al. 1992).”
MethodPrendergast, M., Terry, A. V., Jackson, W. J., Marsh, K. C., Decker, M. W., Arnerić, S. P., Buccafusco, J. J., & Terry, A. V. (1997) · Psychopharmacology · doi:10.1007/s002130050240 · Cited by 43 · cited 2×
“…mulatta, Macaca fascicularis, and Macaca nemestrina) with doses generally ranging from 0.001 to 0.056 mg kg −1 (0.3–18 μg kg −1 ) (Buccafusco and Jackson 1991; Buccafusco et al. 1995, 1999; Elrod et al. 1988; Katner et al. 2004; Prendergast et al. 1997; Terry et al. 1993; Witte et al. 1997).”
BackgroundInfluentialSelf-citationNicotine self-administration in baboons
Ator, N. A., & Griffiths, R. R. (1983) · Pharmacology Biochemistry and Behavior · doi:10.1016/0091-3057(83)90406-9 · Cited by 42 · cited 1×
“3– 180 μg kg) (Ator and Griffiths 1983; Slifer and Balster 1985).”
Kitamoto, T., Ikeda, K., & Salvaterra, P. (1992) · The Journal of Neuroscience · doi:10.1523/jneurosci.12-05-01628.1992 · Cited by 42 · cited 1×
“Complete loss-of-function mutations in ChAT are lethal, although several temperature-sensitive alleles that cause paralysis when shifted to the restrictive temperature as adults have been found (Kitamoto et al. 1992).”
BackgroundMolander, L., Lunell, E., & Fagerström, K. O. (2000) · Nicotine & Tobacco Research · doi:10.1080/713688123 · Cited by 41 · cited 1×
“Chronic kidney disease is associated with reduced nicotine and cotinine renal clearance, as well as a 50% reduction in metabolic clearance of nicotine that may be attributable to inhibition of CYP2A6 activity or downregulation of its expression in the liver (Molander et al. 2000).”
BackgroundDamaj, M. I. (2000) · European Journal of Pharmacology · doi:10.1016/s0014-2999(00)00579-3 · Cited by 41
Self-citationMecamylamine acutely increases human intravenous nicotine self-administration
Rose, J. E., Behm, F. M., Westman, E. C., & Bates, J. E. (2003) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2003.08.011 · Cited by 41 · cited 3×
“In contrast, when nicotine is administered in puff-sized boli (0.1 mg kg −1 per injection), the subjective rewarding and aversive effects are minimal (Rose et al. 2003a–c).”
BackgroundMethodInfluentialSelf-citationAn acute dose of nicotine does not inhibit MAO B in baboon brain in vivo
Fowler, J. S., Volkow, N. D., Logan, J., Pappas, N. R., King, P. T., MacGregor, R. R., Shea, C. E., Garza, V., & Gatley, S. J. (1998) · Life Sciences · doi:10.1016/s0024-3205(98)00251-3 · Cited by 41 · cited 2×
“Baboons (Papio) and rhesus monkeys (M. mulatta) have been given nicotine doses ranging from 5 to 40 μg kg −1 (Ding et al. 2000; Fowler et al. 1998; Valette et al. 2003) or 0.01–0.065 mg kg −1 (3–20 μg kg −1 ) (Marenco et al. 2004).”
MethodInfluentialOverton, D. A. (1979) · Psychopharmacology · doi:10.1007/bf00492218 · Cited by 41 · cited 1×
“The schedule of reinforcement employed in drug discrimination research also influences the characteristics of the cue obtained (Overton 1979).”
BackgroundVentral hippocampal NMDA blockade and nicotinic effects on memory function
Levin, E. D., Sledge, D., Baruah, A., & Addy, N. (2003) · Brain Research Bulletin · doi:10.1016/s0361-9230(03)00183-7 · Cited by 39
Self-citationSquire, M. D., Tornøe, C., Baylis, H. A., Fleming, J. T., Barnard, E. A., & Sattelle, D. B. (1995) · PubMed · Cited by 39
Jonas, P. E., Phannavong, B., Schuster, R., Schröder, C., & Gundelfinger, E. D. (1994) · Journal of Neurobiology · doi:10.1002/neu.480251203 · Cited by 38
Valette, H., Bottlaender, M., Dollé, F., Coulon, C., Ottaviani, M., & Syrota, A. (2003) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2003.01502.x · Cited by 37 · cited 1×
“Baboons (Papio) and rhesus monkeys (M. mulatta) have been given nicotine doses ranging from 5 to 40 μg kg −1 (Ding et al. 2000; Fowler et al. 1998; Valette et al. 2003) or 0.01–0.065 mg kg −1 (3–20 μg kg −1 ) (Marenco et al. 2004).”
InfluentialCarstens, E. E., Simons, C. T., Dessirier, J.-M., Carstens, M. I., & Jinks, S. L. (2000) · Experimental Brain Research · doi:10.1007/s002210000351 · Cited by 37
Stitzel, J. A., Lü, Y., Jimenez, M., Tritto, T., & Collins, A. C. (2000) · Behavioural Brain Research · doi:10.1016/s0166-4328(00)00200-x · Cited by 37 · cited 2×
“The information below is only a brief overview and the interested reader is directed to excellent articles that focus on receptor-related issues (e.g., DajasBailador and Wonnacott 2004; Gotti and Clementi 2004; Hogg et al. 2003; Jones and Sattelle 2004; Leonard and Bertrand 2001; Lindstrom 2003; Lukas et al. 1999; Mac…”
BackgroundSelf-citationCompensation in pre‐synaptic dopaminergic function following nigrostriatal damage in primates
McCallum, S. E., Parameswaran, N., Perez, X. A., Bao, S., McIntosh, J. M., Grady, S. R., & Quik, M. (2006) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2005.03610.x · Cited by 37 · cited 1×
“These nAChRs are functional at both the cellular and whole animal level, e.g., robust nicotine-evoked dopamine release has been identified in monkey striatal synaptosomes (McCallum et al. 2005, 2006).”
BackgroundSelf-citationTakada, K., Swedberg, M. D. B., Goldberg, S. R., & Katz, J. L. (1989) · Psychopharmacology · doi:10.1007/bf00442809 · Cited by 37 · cited 2×
“Cotinine is less effective than nicotine in these tasks, with higher doses (∼2,000×) required in eliciting similar responses (Takada et al. 1989).”
BackgroundInfluentialDifferential behavioral responses to nicotine in Lewis and Fischer-344 rats
Philibin, S. D., Vann, R. E., Varvel, S. A., COVINGTONIII, H., Rosecrans, J. A., JAMES, J., & ROBINSON, S. (2004) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2004.10.009 · Cited by 36 · cited 1×
“2002) and strain differences, indicated by the increased development of CPP in Lewis rats compared to the Fisher 344 strain (Horan et al. 1997; Philibin et al. 2005).”
ResultSemenova, S., & Markou, A. (2003) · Biological Psychiatry · doi:10.1016/s0006-3223(03)00240-3 · Cited by 36
Self-citationInfluence of Route of Administration on Metabolism of [14C]Nicotine in Four Species
Turner, D. M. (1975) · Xenobiotica · doi:10.3109/00498257509056125 · Cited by 36 · cited 1×
“injection, peak brain nicotine levels are observed within approximately 15 min (Turner 1975) and are significantly lower than those achieved by i.”
BackgroundNicotine conditions place preferences after intracerebral administration in rats
Iwamoto, E. T. (1990) · Psychopharmacology · doi:10.1007/bf02244415 · Cited by 35
Liu, J., Mohila, C. A., Gong, Y., Govindarajan, N., & Onn, S. (2005) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.2005.04423.x · Cited by 35 · cited 1×
“When nicotine at 200 μg ml (65 μg ml) is included in the sole source of drinking water supplemented with 2% saccharin for 3 weeks, calcium-binding proteins in GABA neurons of the adolescent accumbens are upregulated (Liu et al. 2005).”
MethodIntravenous self-administration of nicotine: With and without schedule-induction
Slifer, B. L., & Balster, R. L. (1985) · Pharmacology Biochemistry and Behavior · doi:10.1016/0091-3057(85)90487-3 · Cited by 35 · cited 1×
“3– 180 μg kg) (Ator and Griffiths 1983; Slifer and Balster 1985).”
Semenova, S., Bespalov, A., & Markou, A. (2003) · European Journal of Pharmacology · doi:10.1016/s0014-2999(03)01904-6 · Cited by 35 · cited 2×
“self-administration of nicotine (Martellotta et al. 1995; Semenova et al. 2003), and anxiolytic responses, including elevated plus maze (Brioni et al.”
BackgroundSelf-citationMatta, S. G., McCoy, J. G., Foster, C. A., & Sharp, B. M. (1995) · Neuroendocrinology · doi:10.1159/000126860 · Cited by 35
Self-citationHou, J., Kuromi, H., Fukasawa, Y., Ueno, K., Sakai, T., & Kidokoro, Y. (2004) · Journal of Neurobiology · doi:10.1002/neu.20021 · Cited by 35
Cigarette smoking in rhesus monkeys
Ando, K., & Yanagita, T. (1981) · Psychopharmacology · doi:10.1007/bf00431644 · Cited by 35 · cited 1×
“Studies examining the effects of smoking in nonhuman primates are at present quite limited, most likely due to difficulties of administration via this route (Ando and Yanagita 1981).”
BackgroundMeyer, E. L., Xiao, Y., & Kellar, K. J. (2001) · Molecular Pharmacology · doi:10.1016/s0026-895x(24)12620-x · Cited by 35 · cited 1×
“This is, perhaps, surprising because it has been shown that the receptors mediating this response are desensitized fairly rapidly and remain desensitized after an acute injection of nicotine (Balfour et al. 2000; Meyer et al. 2001; Olale et al. 1997; Pidoplichko et al. 1997).”
BackgroundBuccafusco, J. J., Jackson, W. J., Jonnala, R. R., & Terry, A. V. (1999) · Behavioural Pharmacology · doi:10.1097/00008877-199911000-00015 · Cited by 34 · cited 3×
“In this procedure, the optimal dose for each subject is identified in an initial dose study, followed by hypothesis testing with a dose range centered around this individual optimum (Buccafusco and Jackson 1991; Buccafusco et al. 1999).”
BackgroundInfluentialSelf-citationStolerman, I. P. (1988) · Pharmacology Biochemistry and Behavior · doi:10.1016/0091-3057(88)90451-0 · Cited by 33
Self-citationFu, Y., Matta, S. G., McIntosh, J. M., & Sharp, B. M. (1999) · Neuroscience Letters · doi:10.1016/s0304-3940(99)00293-1 · Cited by 32
Self-citationRobinson, S. F., Grun, E. U., Pauly, J. R., & Collins, A. C. (1996) · Pharmacology Biochemistry and Behavior · doi:10.1016/0091-3057(95)02281-3 · Cited by 32
de Fiebre, N. C., Dawson, R., & de Fiebre, C. M. (2002) · Alcoholism Clinical and Experimental Research · doi:10.1111/j.1530-0277.2002.tb02603.x · Cited by 32
Ashton, K., Wagoner, A. P., Carrillo, R. J., & Gibson, G. C. (2001) · Genetics · doi:10.1093/genetics/157.1.283 · Cited by 32
Discrimination Learning with Drug Stimuli: Methods and Applications
Järbe, T. U. C. (2003) · Psychopharmacology · doi:10.1385/0-89603-129-2:513 · Cited by 32
Research works printed but not linked: 3
- Dworkin SI, Vrana SL, Broadbent J, Robinson J (1993) Comparing the reinforcing effects of nicotine, caffeine, methylphenidate and cocaine. Med Chem Res 2:593–602
- Järbe TUC (1989) Discrimination learning with drug stimuli. In: Boulton AA, Baker GB, Greenshaw AJ (eds) Neuromethods, vol 13. Humana, Clifton, New Jersey, pp 513–563
- Levin ED, Christopher NC, Briggs SJ (1994) Comparison of chronic nicotine and mecamylamine effects on working memory performance in the radial-arm maze and T-maze alternation. Soc Neurosci Abs 20:151
Cited by
Habenular α5 nicotinic receptor subunit signalling controls nicotine intake
Fowler, C. D., Lu, Q., Johnson, P. M., Marks, M. J., & Kenny, P. J. (2011) · Nature · doi:10.1038/nature09797 · Cited by 663
Self-citationPICCIOTTO, M., ADDY, N., MINEUR, Y., & BRUNZELL, D. (2008) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2007.12.005 · Cited by 460
Self-citationNicotine Decreases Food Intake Through Activation of POMC Neurons
Mineur, Y. S., Abizaid, A., Rao, Y., Salas, R., DiLeone, R. J., Gündisch, D., Diano, S., De Biasi, M., Horvath, T. L., Gao, X.-B., et al. (2011) · Science · doi:10.1126/science.1201889 · Cited by 439
Self-citationPhasic Dopamine Release Evoked by Abused Substances Requires Cannabinoid Receptor Activation
Cheer, J. F., Wassum, K. M., Sombers, L. A., Heien, M. L. A. V., Ariansen, J. L., Aragona, B. J., Phillips, P. E. M., & Wightman, R. M. (2007) · The Journal of Neuroscience · doi:10.1523/jneurosci.4152-06.2007 · Cited by 374
“3 mg/kg) were administered intravenously at doses demonstrated previously to have robust effects either on dopamine extracellular concentrations or behavior (Di Chiara and Imperato, 1988; Budygin et al., 2001; Robinson et al., 2002a; Heien et al., 2005; Matta et al., 2006).”
MethodInfluentialNicotine and the renin-angiotensin system
Oakes, J. M., Fuchs, R. M., Gardner, J. D., Lazartigues, E., & Yue, X. (2018) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.00099.2018 · Cited by 312
Metadata
- Authors
- Matta, S. G., Balfour, D. J., Benowitz, N. L., Boyd, R. T., Buccafusco, J. J., Caggiula, A. R., Craig, C. R., Collins, A. C., Damaj, M. I., Donny, E. C., Gardiner, P. S., Grady, S. R., Heberlein, U., Leonard, S. S., Levin, E. D., Lukas, R. J., Markou, A., Marks, M. J., McCallum, S. E., Parameswaran, N., Perkins, K. A., Picciotto, M. R., Quik, M., Rose, J. E., Rothenfluh, A., Schafer, W. R., Stolerman, I. P., Tyndale, R. F., Wehner, J. M., & Zirger, J. M.
- Affiliations
- University of Tennessee Health Science Center (US)
- University of Dundee (GB)
- University of California, San Francisco (US)
- The Ohio State University (US)
- Augusta University (US)
- University of Pittsburgh (US)
- University of California San Diego (US)
- University of Colorado Boulder (US)
- Virginia Commonwealth University (US)
- University of California System (US)
- University of Colorado Health (US)
- Duke Medical Center (US)
- Barrow Neurological Institute (US)
- Parkinson's Institute and Clinical Center (US)
- Yale University (US)
- King's College London (GB)
- Centre for Addiction and Mental Health (CA)
- Corresponding author
- Matta, Shannon G.
- ORCID
- Venue
- Psychopharmacology
- Published
- 2006-08-09
- Volume
- 190
- Issue
- 3
- Pages
- 269-319
- ISSN
- 0033-3158 (ISSN-L)
- 1432-2072
- OpenAlex
- W2151079096
- Semantic Scholar
- a869fec78dfce26c04bde5b3ac55aa2e33388cc6
- Cited by
- 824
- References
- 446
- Citations by year
- 2026: 23 · 2025: 27 · 2024: 35 · 2023: 35 · 2022: 34 · 2021: 44 · 2020: 48 · 2019: 48 · 2018: 42 · 2017: 54 · 2016: 51 · 2015: 66 · 2014: 56 · 2013: 63 · 2012: 53
- FWCI
- 3.33
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Psychopharmacology (publishedVersion)
- PubMed (publishedVersion)
- Lirias (submittedVersion)
- Topics
- Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Smoking Behavior and Cessation
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Nicotinic Acetylcholine Receptors Study
- Health Sciences › Veterinary › Small Animals › Animal testing and alternatives
- Keywords
- nicotine, dose selection, dosing regimen, route of administration, species differences, nicotine metabolism, dose-response relationship, nicotine dependence, nicotine tolerance, nicotine withdrawal, nicotine replacement therapy, cigarette smoking, animal models, Drosophila, Caenorhabditis elegans, zebrafish, rats, mice, non-human primates
- MeSH terms
- Animals, Dose-Response Relationship, Drug, Ganglionic Stimulants, Humans, Models, Biological, Nicotine, Species Specificity, Guidelines as Topic, Behavioral Research
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.